Exelixis
EXEL
#1773
Rank
A$15.23 B
Marketcap
$53.35
Share price
0.67%
Change (1 day)
61.27%
Change (1 year)
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

We have found no dividend yield history for this company